Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Goldenwell Biotech (GWLL) Times Interest Earned (2020 - 2025)

Goldenwell Biotech filings provide 4 years of Times Interest Earned readings, the most recent being -$2.8 for Q3 2025.

  • On a quarterly basis, Times Interest Earned rose 71.93% to -$2.8 in Q3 2025 year-over-year; TTM through Sep 2025 was $5.33, a 134.93% increase, with the full-year FY2024 number at -$3.29, up 79.54% from a year prior.
  • Times Interest Earned hit -$2.8 in Q3 2025 for Goldenwell Biotech, down from -$1.49 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $17.18 in Q4 2024 to a low of -$343.85 in Q3 2021.
  • Median Times Interest Earned over the past 3 years was -$3.11 (2024), compared with a mean of -$40.57.
  • Biggest five-year swings in Times Interest Earned: crashed 94.48% in 2021 and later skyrocketed 93.48% in 2025.
  • Goldenwell Biotech's Times Interest Earned stood at $5.15 in 2021, then surged by 233.57% to $17.18 in 2024, then crashed by 116.31% to -$2.8 in 2025.
  • The last three reported values for Times Interest Earned were -$2.8 (Q3 2025), -$1.49 (Q2 2025), and -$3.44 (Q1 2025) per Business Quant data.